BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36030579)

  • 1. IV tPA for acute ischemic stroke in the setting of intracranial tumor: A scoping review.
    Moran CE; Rubin MN
    J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106741. PubMed ID: 36030579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis.
    Goh S; Tan NHW; Tan CH; Leow AST; Sia CH; Ho AFW; Lim MJR; Yeo LLL; Tan BYQ
    J Thromb Thrombolysis; 2022 Feb; 53(2):485-494. PubMed ID: 34302590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA.
    Shah K; Clark A; Desai SM; Jadhav AP
    Neurocrit Care; 2022 Feb; 36(1):123-129. PubMed ID: 34228264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.
    AbdelRazek MA; Mowla A; Hojnacki D; Zimmer W; Elsadek R; Abdelhamid N; Elsadek L; Farooq S; Kamal H; Crumlish A; Shirani P; Ching M; Sawyer R
    Cerebrovasc Dis; 2015; 40(5-6):201-4. PubMed ID: 26402147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
    Ranasinghe T; Mays T; Quedado J; Adcock A
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
    Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms.
    Goyal N; Tsivgoulis G; Zand R; Sharma VK; Barlinn K; Male S; Katsanos AH; Bodechtel U; Iftikhar S; Arthur A; Elijovich L; Alexandrov AW; Alexandrov AV
    Neurology; 2015 Oct; 85(17):1452-8. PubMed ID: 26408492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IV Thrombolysis With or Without Endovascular Treatment for Suspected Ischemic Stroke in Patients With Intracranial Tumors.
    Seystahl K; Martinez-Majander N; Salerno A; Beyeler M; Erdur H; Marto JP; Hametner C; Zedde M; Pezzini A; Leker R; Altersberger V; Costamagna G; Serôdio M; Migliaccio L; Pascarella R; Zini A; Mannismäki L; Béjot Y; Jung S; Gensicke H; Padjen V; Ringleb PA; Nolte C; Heldner MR; Michel P; Engelter ST; Curtze S; Weller M; Wegener S
    Neurology; 2023 Sep; 101(12):e1241-e1255. PubMed ID: 37463747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysis.
    Al-Salihi MM; Saha R; Ayyad A; Al-Jebur MS; Al-Salihi Y; Roy A; Dalal SS; Rivet D; Spiotta AM; Qureshi AI
    Clin Neurol Neurosurg; 2024 Jan; 236():108097. PubMed ID: 38176219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
    Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
    Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Mowla A; Kamal H; Lail NS; Vaughn C; Shirani P; Mehla S; Rajabzadeh-Oghaz H; Deline C; Ching M; Crumlish A; Sawyer RN
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1414-1418. PubMed ID: 28438515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
    Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
    Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.